Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

1.

Polygenic Overlap Between C-Reactive Protein, Plasma Lipids and Alzheimer's Disease.

Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, Chasman DI, McEvoy LK, Holland D, Chen CH, Karow DS, Brewer JB, Hess CP, Williams J, Sims R, O'Donovan MC, Choi SH, Bis JC, Ikram MA, Gudnason V, DeStefano AL, van der Lee SJ, Psaty BM, van Duijn CM, Launer L, Seshadri S, Pericak-Vance MA, Mayeux R, Haines JL, Farrer LA, Hardy J, Ulstein ID, Aarsland D, Fladby T, White LR, Sando SB, Rongve A, Witoelar A, Djurovic S, Hyman BT, Snaedal J, Steinberg S, Stefansson H, Stefansson K, Schellenberg GD, Andreassen OA, Dale AM.

Circulation. 2015 Apr 10. pii: CIRCULATIONAHA.115.015489. [Epub ahead of print]

PMID:
25862742
2.

Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms.

Andreassen OA, Desikan RS, Wang Y, Thompson WK, Schork AJ, Zuber V, Doncheva NT, Ellinghaus E, Albrecht M, Mattingsdal M, Franke A, Lie BA, Mills I, Aukrust P, McEvoy LK, Djurovic S, Karlsen TH, Dale AM.

PLoS One. 2015 Apr 8;10(4):e0123057. doi: 10.1371/journal.pone.0123057. eCollection 2015.

3.

Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus.

Desikan RS, Schork AJ, Wang Y, Witoelar A, Sharma M, McEvoy LK, Holland D, Brewer JB, Chen CH, Thompson WK, Harold D, Williams J, Owen MJ, O'Donovan MC, Pericak-Vance MA, Mayeux R, Haines JL, Farrer LA, Schellenberg GD, Heutink P, Singleton AB, Brice A, Wood NW, Hardy J, Martinez M, Choi SH, DeStefano A, Ikram MA, Bis JC, Smith A, Fitzpatrick AL, Launer L, van Duijn C, Seshadri S, Ulstein ID, Aarsland D, Fladby T, Djurovic S, Hyman BT, Snaedal J, Stefansson H, Stefansson K, Gasser T, Andreassen OA, Dale AM.

Mol Psychiatry. 2015 Feb 17. doi: 10.1038/mp.2015.6. [Epub ahead of print]

PMID:
25687773
4.

Plasma leptin levels are not predictive of dementia in patients with mild cognitive impairment.

Oania R, McEvoy LK.

Age Ageing. 2015 Jan;44(1):53-8. doi: 10.1093/ageing/afu160. Epub 2014 Oct 27.

PMID:
25349150
5.

Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.

Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M, Zuber V, Bettella F, Ripke S, Kelsoe JR, Kendler KS, O'Donovan MC, Sklar P; Psychiatric Genomics Consortium (PGC) Bipolar Disorder and Schizophrenia Work Groups; International Multiple Sclerosis Genetics Consortium (IMSGC), McEvoy LK, Desikan RS, Lie BA, Djurovic S, Dale AM.

Mol Psychiatry. 2015 Feb;20(2):207-14. doi: 10.1038/mp.2013.195. Epub 2014 Jan 28.

6.

Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes.

Andreassen OA, McEvoy LK, Thompson WK, Wang Y, Reppe S, Schork AJ, Zuber V, Barrett-Connor E, Gautvik K, Aukrust P, Karlsen TH, Djurovic S, Desikan RS, Dale AM; International Consortium for Blood Pressure Genome-Wide Association Studies, Genetic Factors for Osteoporosis Consortium.

Hypertension. 2014 Apr;63(4):819-26. doi: 10.1161/HYPERTENSIONAHA.113.02077. Epub 2014 Jan 6.

7.

The role of clusterin in amyloid-β-associated neurodegeneration.

Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H, Blennow K, Andreassen OA, McEvoy LK, Hyman BT, Dale AM; Alzheimer’s Disease Neuroimaging Initiative Group.

JAMA Neurol. 2014 Feb;71(2):180-7. doi: 10.1001/jamaneurol.2013.4560.

8.

Fetuin-A, a new vascular biomarker of cognitive decline in older adults.

Laughlin GA, McEvoy LK, Barrett-Connor E, Daniels LB, Ix JH.

Clin Endocrinol (Oxf). 2014 Jul;81(1):134-40. doi: 10.1111/cen.12382. Epub 2014 Jan 7.

PMID:
24325554
9.

Heart fatty acid binding protein and Aβ-associated Alzheimer's neurodegeneration.

Desikan RS, Thompson WK, Holland D, Hess CP, Brewer JB, Zetterberg H, Blennow K, Andreassen OA, McEvoy LK, Hyman BT, Dale AM; Alzheimer’s Disease Neuroimaging Initiative.

Mol Neurodegener. 2013 Oct 2;8:39. doi: 10.1186/1750-1326-8-39.

10.

APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.

Chang YL, Fennema-Notestine C, Holland D, McEvoy LK, Stricker NH, Salmon DP, Dale AM, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 May;10(3):336-48. doi: 10.1016/j.jalz.2013.05.1763. Epub 2013 Jul 27.

PMID:
23896613
11.

Changes in alcohol intake and their relationship with health status over a 24-year follow-up period in community-dwelling older adults.

McEvoy LK, Kritz-Silverstein D, Barrett-Connor E, Bergstrom J, Laughlin GA.

J Am Geriatr Soc. 2013 Aug;61(8):1303-8. doi: 10.1111/jgs.12366. Epub 2013 Jul 18.

12.

Higher rates of decline for women and apolipoprotein E epsilon4 carriers.

Holland D, Desikan RS, Dale AM, McEvoy LK; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2013 Dec;34(12):2287-93. doi: 10.3174/ajnr.A3601. Epub 2013 Jul 4.

13.
14.

Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors.

Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O'Donovan MC, Rujescu D, Werge T, van de Bunt M, Morris AP, McCarthy MI; International Consortium for Blood Pressure GWAS; Diabetes Genetics Replication and Meta-analysis Consortium; Psychiatric Genomics Consortium Schizophrenia Working Group, Roddey JC, McEvoy LK, Desikan RS, Dale AM.

Am J Hum Genet. 2013 Feb 7;92(2):197-209. doi: 10.1016/j.ajhg.2013.01.001. Epub 2013 Jan 31.

15.

Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES).

Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ, Simon RD Jr, Guilleminault C, White DP, Goodwin JL, Schweitzer PK, Leary EB, Hyde PR, Hirshkowitz M, Green S, McEvoy LK, Chan C, Gevins A, Kay GG, Bloch DA, Crabtree T, Dement WC.

Sleep. 2012 Dec 1;35(12):1593-602. doi: 10.5665/sleep.2226.

16.

Enrichment and stratification for predementia Alzheimer disease clinical trials.

Holland D, McEvoy LK, Desikan RS, Dale AM; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2012;7(10):e47739. doi: 10.1371/journal.pone.0047739. Epub 2012 Oct 17.

17.

Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease.

Desikan RS, McEvoy LK, Holland D, Thompson WK, Brewer JB, Aisen PS, Andreassen OA, Hyman BT, Sperling RA, Dale AM; Alzheimer's Disease Neuroimaging Initiative.

AJNR Am J Neuroradiol. 2013 Mar;34(3):505-10. doi: 10.3174/ajnr.A3267. Epub 2012 Sep 13.

18.

Age-related changes in the neurophysiology of language in adults: relationship to regional cortical thinning and white matter microstructure.

Kemmotsu N, Girard HM, Kucukboyaci NE, McEvoy LK, Hagler DJ Jr, Dale AM, Halgren E, McDonald CR.

J Neurosci. 2012 Aug 29;32(35):12204-13. doi: 10.1523/JNEUROSCI.0136-12.2012.

19.

Higher education is not associated with greater cortical thickness in brain areas related to literacy or intelligence in normal aging or mild cognitive impairment.

Pillai JA, McEvoy LK, Hagler DJ Jr, Holland D, Dale AM, Salmon DP, Galasko D, Fennema-Notestine C; Alzheimer's Disease Neuroimaging Initiative.

J Clin Exp Neuropsychol. 2012;34(9):925-35. doi: 10.1080/13803395.2012.702733. Epub 2012 Aug 21.

20.

Rates of decline in Alzheimer disease decrease with age.

Holland D, Desikan RS, Dale AM, McEvoy LK; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2012;7(8):e42325. Epub 2012 Aug 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk